SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-005879
Filing Date
2018-03-15
Accepted
2018-03-15 17:16:45
Documents
91
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cara-10k_20171231.htm 10-K 3613033
2 EX-23.1 cara-ex231_239.htm EX-23.1 7575
3 EX-31.1 cara-ex311_240.htm EX-31.1 15712
4 EX-31.2 cara-ex312_241.htm EX-31.2 15575
5 EX-32.1 cara-ex321_242.htm EX-32.1 9489
6 GRAPHIC g2018031520462595211246.jpg GRAPHIC 19561
  Complete submission text file 0001564590-18-005879.txt   11971287

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cara-20171231.xml EX-101.INS 2769827
8 XBRL TAXONOMY EXTENSION SCHEMA cara-20171231.xsd EX-101.SCH 64281
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20171231_cal.xml EX-101.CAL 64722
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20171231_def.xml EX-101.DEF 274494
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20171231_lab.xml EX-101.LAB 515613
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20171231_pre.xml EX-101.PRE 445917
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36279 | Film No.: 18693341
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences